Results 1 to 10 of about 117,301 (397)
Selective serotonin reuptake inhibitors and Alzheimer’s disease
Neural Regeneration Research, 2020 Given the failure to develop disease-modifying therapies for Alzheimer’s disease (AD), strategies aiming at preventing or delaying the onset of the disease are being prioritized. While the debate regarding whether depression is an etiological risk factor
Bernadette Mdawar +2 more
doaj +5 more sources
Selective serotonin reuptake inhibitors for fibromyalgia syndrome [PDF]
São Paulo Medical Journal, 2015 BACKGROUND: Fibromyalgia is a clinically well-defined chronic condition with a biopsychosocial aetiology. Fibromyalgia is characterized by chronic widespread musculoskeletal pain, sleep problems, cognitive dysfunction, and fatigue. Patients often report
Brian Walitt +4 more
doaj +9 more sources
Sentiment Analysis of Online Reviews for Selective Serotonin Reuptake Inhibitors and Serotonin–Norepinephrine Reuptake Inhibitors [PDF]
Pharmacy, 2021 Background: Depression affects millions worldwide, with drug therapy being the mainstay treatment. A variety of factors, including personal reviews, are involved in the success or failure of medication therapy.
Chad Compagner +2 more
doaj +4 more sources
Dosing of Selective Serotonin Reuptake Inhibitors [PDF]
The Primary Care Companion For CNS Disorders, 2001 Sir: I am writing to address an inaccuracy written about the dosing and administration of selective serotonin reuptake inhibitor (SSRI) medications in the article by Marken and Munro published in the December 2000 issue of the Companion.1 Contrary to the contention by Drs. Marken and Munro that sertraline is more effective at the high end of the dosage
Henry Chung
openalex +4 more sources
Remission rates during treatment with venlafaxine or selective serotonin reuptake inhibitors [PDF]
British Journal of Psychiatry, 2001 Michael E. Thase +2 more
openalex +2 more sources
Selective serotonin reuptake inhibitors (SSRIs) for stroke recovery
São Paulo Medical Journal, 2013 BACKGROUND Stroke is the major cause of adult disability. Selective serotonin reuptake inhibitors (SSRIs) have been used for many years to manage depression. Recently, small trials have demonstrated that SSRIs might improve recovery after stroke, even in
Gillian E. Mead +6 more
doaj +2 more sources
Selective serotonin reuptake inhibitors [PDF]
BMJ, 2004 The increasing use of antidepressants—particularly the selective serotonin reuptake inhibitors (SSRIs)—might be grounds for optimism because it might indicate that one of the great health problems of our age is increasingly being recognised and treated. Instead SSRIs have become embroiled in controversy over both their effectiveness and safety. As well
Geddes J., CIPRIANI, Andrea
openaire +6 more sources
Selective Serotonin Reuptake Inhibitors and Adverse Effects: A Narrative Review
Neurology International, 2021 Depression is the most prevalent psychiatric disorder in the world, affecting 4.4% of the global population. Despite an array of treatment modalities, depressive disorders remain difficult to manage due to many factors. Beginning with the introduction of
Amber N. Edinoff +11 more
semanticscholar +1 more source
Selective serotonin reuptake inhibitors and risk for gastrointestinal bleeding [PDF]
Opšta Medicina, 2014 The most of the known effects of selective serotonin reuptake inhibitors, beneficial or harmful, are associated with the inhibitory action of the serotonin reuptake transporter.
Batić-Mujanović Olivera +2 more
doaj +1 more source